Alliance Pharma PLC Pre-Close Trading Update (8331S)
July 13 2015 - 1:00AM
UK Regulatory
TIDMAPH
RNS Number : 8331S
Alliance Pharma PLC
13 July 2015
13 July 2015
ALLIANCE PHARMA PLC
("Alliance" or the "Group")
Pre-Close Trading Update
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical
company, announces its pre-close trading update ahead of the
announcement of its interim results for the six months ended 30
June 2015.
The Group continues to perform well and in line with
management's expectations, with sales of approximately GBP22.8m (H1
2014: GBP21.4m) in the first half of the year.
Our growth products continue to deliver, with Hydromol(TM)
generating sales of GBP3.3m in the period, 10% higher than in the
same period in the prior year despite the additional PPRS rebate
deduction.
MacuShield(TM), acquired in February this year, is performing in
line with expectations and we look forward to the return of
ImmuCyst in the second half of the year, although volumes remain
uncertain as Sanofi's facility ramps up production.
Alliance continues to explore a number of acquisition
opportunities and remains confident of the outlook for the full
year.
The Company's interim results for the six months ended 30 June
2015 are scheduled to be released on 9 September 2015.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Buchanan + 44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Jane
Glover
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade /
Freddie Barnfield
Corporate Broking: David Poutney
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to
established niche products and owns or licenses the rights to more
than 60 pharmaceutical products and continues to explore
opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTSFUSIDFISELW
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024